<?xml version="1.0" encoding="UTF-8"?>
<!-- adm-news-sitemap generated=2026-11-10T03:37:13Z -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
	<url>
		<loc>https://aidiagme.com/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS Trial: Ziltivekimab Cut hs-CRP but Not Heart Attacks]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/pt-br/noticias-medicas/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>pt</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Estudo ZEUS: ziltivekimab baixou a PCR ultrassensível, mas não os infartos]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/it/notizie-mediche/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>it</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Studio ZEUS: ziltivekimab riduce la PCR-hs ma non gli infarti]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/de/medizinische-nachrichten/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-Studie: Ziltivekimab senkt hs-CRP, aber keine Herzinfarkte]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/es/noticias-medicas/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>es</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Ensayo ZEUS: el ziltivekimab bajó la PCR ultrasensible, pero no los infartos]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/zh_cn/%e5%8c%bb%e5%ad%a6%e6%96%b0%e9%97%bb/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>zh-cn</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS试验：ziltivekimab降低了hs-CRP，却没有减少心肌梗死]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/hi/%e0%a4%9a%e0%a4%bf%e0%a4%95%e0%a4%bf%e0%a4%a4%e0%a5%8d%e0%a4%b8%e0%a4%be-%e0%a4%b8%e0%a4%ae%e0%a4%be%e0%a4%9a%e0%a4%be%e0%a4%b0/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>hi</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS ट्रायल: ज़िल्टिवेकिमैब ने hs-CRP घटाया, पर हार्ट अटैक नहीं]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ar/%d8%a3%d8%ae%d8%a8%d8%a7%d8%b1-%d8%b7%d8%a8%d9%8a%d8%a9/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ar</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[تجربة ZEUS: زيلتيفيكيماب خفّض hs-CRP لكنه لم يقلّل النوبات القلبية]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/id/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>id</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Uji ZEUS: Ziltivekimab Turunkan hs-CRP, tetapi Tidak Serangan Jantung]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/sv/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>sv</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-studien: ziltivekimab sänkte hs-CRP men inte antalet hjärtinfarkter]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/fi/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>fi</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-tutkimus: ziltivekimabi laski hs-CRP:tä mutta ei sydäninfarkteja]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/nl/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>nl</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-studie: ziltivekimab verlaagt hs-CRP, maar niet het aantal hartinfarcten]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ru/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ru</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Исследование ZEUS: зилтивекимаб снизил вчСРБ, но не число инфарктов]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ro/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ro</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Studiul ZEUS: ziltivekimab scade hs-CRP, dar nu și infarctele]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ja/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ja</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS試験：ziltivekimabで高感度CRPは下がったが心筋梗塞は減らず]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ko/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ko</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS 시험: ziltivekimab, hs-CRP는 낮췄지만 심근경색은 못 줄였다]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/he/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>he</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ניסוי ZEUS: זילטיבקימאב הוריד את ה-hs-CRP אבל לא את התקפי הלב]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/es_mx/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>es</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Estudio ZEUS: el ziltivekimab bajó la PCR ultrasensible, pero no los infartos]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/en_gb/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS Trial: Ziltivekimab Cut hs-CRP but Not Heart Attacks]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/pt/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>pt</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Ensaio ZEUS: ziltivekimab baixou a PCR de alta sensibilidade, mas não os enfartes]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/th/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>th</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[การศึกษา ZEUS: ziltivekimab ลด hs-CRP ได้ แต่ไม่ลดภาวะหัวใจขาดเลือด]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/tr/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>tr</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS Çalışması: Ziltivekimab hs-CRP'yi Düşürdü, Kalp Krizlerini Değil]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/tw/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>zh-tw</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS試驗：ziltivekimab降低了hs-CRP，卻沒有減少心肌梗塞]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/pl/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>pl</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Badanie ZEUS: ziltivekimab obniżył hs-CRP, ale nie liczbę zawałów]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/vi/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>vi</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Thử nghiệm ZEUS: Ziltivekimab giảm hs-CRP nhưng không giảm nhồi máu cơ tim]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/el/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>el</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Μελέτη ZEUS: το ziltivekimab μείωσε την hs-CRP, όχι τα εμφράγματα]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/sr/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>sr</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Studija ZEUS: ziltivekimab snizio hs-CRP, ali ne i broj srčanih udara]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/cs/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>cs</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Studie ZEUS: ziltivekimab snížil hsCRP, ale ne počet infarktů]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/hu/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>hu</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-vizsgálat: a ziltivekimab csökkentette a hs-CRP-t, a szívinfarktusokat nem]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/bg/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>bg</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Проучването ZEUS: зилтивекимаб понижи hs-CRP, но не и инфарктите]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/lo/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>lo</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ການທົດລອງ ZEUS: ziltivekimab ຫຼຸດ hs-CRP ໄດ້ ແຕ່ບໍ່ຫຼຸດຫົວໃຈວາຍ]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/fr_ca/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Étude ZEUS : le ziltivekimab abaisse la CRP-hs, mais pas les crises cardiaques]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/sk/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>sk</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Štúdia ZEUS: ziltivekimab znížil hsCRP, ale nie počet infarktov]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/nb/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>nb</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-studien: ziltivekimab senket hs-CRP, men ikke antall hjerteinfarkter]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ka/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ka</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[კვლევა ZEUS: ზილტივეკიმაბმა hs-CRP შეამცირა, ინფარქტები კი არა]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/hr/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>hr</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Studija ZEUS: ziltivekimab snizio hs-CRP, ali ne i broj srčanih udara]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/da/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>da</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-forsøget: ziltivekimab sænkede hs-CRP, men ikke antallet af blodpropper]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/fa/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>fa</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[کارآزمایی ZEUS: زیلتیوکیماب hs-CRP را کم کرد، اما حمله قلبی را نه]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/ur/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>ur</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS ٹرائل: زلٹیویکیمیب نے hs-CRP کم کیا لیکن ہارٹ اٹیک نہیں]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/is/medical-news/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>is</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS-rannsóknin: ziltivekimab lækkaði hs-CRP en fækkaði ekki hjartaáföllum]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/sq/lajme-mjekesore/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>sq</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[Studimi ZEUS: ziltivekimabi uli hs-CRP, por jo infarktet]]></news:title>
		</news:news>
	</url>
	<url>
		<loc>https://aidiagme.com/lt/medicinos-naujienos/zeus-trial-ziltivekimab-hs-crp/</loc>
		<news:news>
			<news:publication>
				<news:name>AI DiagMe</news:name>
				<news:language>lt</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T03:36:48+00:00</news:publication_date>
			<news:title><![CDATA[ZEUS tyrimas: ziltivekimabas sumažino hs-CRB, bet ne infarktų skaičių]]></news:title>
		</news:news>
	</url>
</urlset>
